![Peter Forsell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 7 460 M $ op 31-05-2026
Dr. Peter Forsell is a Chief Executive Officer at Implantica AG.
Dr. Forsell was previously employed as an Executive Chairman by Obtech Medical AG and a Chairman by OBTECH Medical SARL. He received his undergraduate degree from Karolinska Institutet.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMPLANTICA AG 100% | 31-12-2024 | 1.125.000.000 ( 100% ) | 7 323 M $ | 31-05-2026 |
IMPLANTICA AG CLASS A 36,34% | 31-12-2024 | 21.116.770 ( 36,34% ) | 137 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IMPLANTICA AG | Algemeen Directeur | 01-01-2015 |
| Bedrijven | Functie | Einde |
|---|---|---|
Obtech Medical AG | Oprichter | - |
OBTECH Medical SARL
 OBTECH Medical SARL Pharmaceuticals: MajorHealth Technology Develops and markets products which promote long-term weight loss in people with morbid obesity | Voorzitter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OBTECH Medical SARL
OBTECH Medical SARL Pharmaceuticals: MajorHealth Technology Develops and markets products which promote long-term weight loss in people with morbid obesity | Health Technology |
Implantica AG
 Implantica AG Medical SpecialtiesHealth Technology Manufactures medical implants | Health Technology |
Obtech Medical AG |
Kies jouw editie
Alle financiële informatie op nationaal niveau
